180 related articles for article (PubMed ID: 24459036)
1. De novo single exon deletion of AUTS2 in a patient with speech and language disorder: a review of disrupted AUTS2 and further evidence for its role in neurodevelopmental disorders.
Amarillo IE; Li WL; Li X; Vilain E; Kantarci S
Am J Med Genet A; 2014 Apr; 164A(4):958-65. PubMed ID: 24459036
[TBL] [Abstract][Full Text] [Related]
2. De novo exon 1 deletion of AUTS2 gene in a patient with autism spectrum disorder and developmental delay: a case report and a brief literature review.
Liu Y; Zhao D; Dong R; Yang X; Zhang Y; Tammimies K; Uddin M; Scherer SW; Gai Z
Am J Med Genet A; 2015 Jun; 167(6):1381-5. PubMed ID: 25851617
[TBL] [Abstract][Full Text] [Related]
3. Exonic deletions of AUTS2 in Chinese patients with developmental delay and intellectual disability.
Fan Y; Qiu W; Wang L; Gu X; Yu Y
Am J Med Genet A; 2016 Feb; 170A(2):515-522. PubMed ID: 26545289
[TBL] [Abstract][Full Text] [Related]
4. Germ cell mosaicism for AUTS2 exon 6 deletion.
Gieldon L; Jauch A; Obeid K; Kaufmann L; Hinderhofer K; Haug U; Moog U
Am J Med Genet A; 2021 Apr; 185(4):1261-1265. PubMed ID: 33577136
[TBL] [Abstract][Full Text] [Related]
5. Whole Exome Sequencing Reveals a Novel
Palumbo P; Di Muro E; Accadia M; Benvenuto M; Di Giacomo MC; Castellana S; Mazza T; Castori M; Palumbo O; Carella M
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33562463
[TBL] [Abstract][Full Text] [Related]
6. De novo small deletion affecting transcription start site of short isoform of AUTS2 gene in a patient with syndromic neurodevelopmental defects.
Martinez-Delgado B; Lopez-Martin E; Lara-Herguedas J; Monzon S; Cuesta I; Juliá M; Aquino V; Rodriguez-Martin C; Damian A; Gonzalo I; Gomez-Mariano G; Baladron B; Cazorla R; Iglesias G; Roman E; Ros P; Tutor P; Mellor S; Jimenez C; Cabrejas MJ; Gonzalez-Vioque E; Alonso J; Bermejo-Sánchez E; Posada M
Am J Med Genet A; 2021 Mar; 185(3):877-883. PubMed ID: 33346930
[TBL] [Abstract][Full Text] [Related]
7. Detection of copy-number variation in AUTS2 gene by targeted exonic array CGH in patients with developmental delay and autistic spectrum disorders.
Nagamani SC; Erez A; Ben-Zeev B; Frydman M; Winter S; Zeller R; El-Khechen D; Escobar L; Stankiewicz P; Patel A; Cheung SW
Eur J Hum Genet; 2013 Mar; 21(3):343-6. PubMed ID: 22872102
[TBL] [Abstract][Full Text] [Related]
8. A detailed clinical analysis of 13 patients with AUTS2 syndrome further delineates the phenotypic spectrum and underscores the behavioural phenotype.
Beunders G; van de Kamp J; Vasudevan P; Morton J; Smets K; Kleefstra T; de Munnik SA; Schuurs-Hoeijmakers J; Ceulemans B; Zollino M; Hoffjan S; Wieczorek S; So J; Mercer L; Walker T; Velsher L; ; Parker MJ; Magee AC; Elffers B; Kooy RF; Yntema HG; Meijers-Heijboer EJ; Sistermans EA
J Med Genet; 2016 Aug; 53(8):523-32. PubMed ID: 27075013
[TBL] [Abstract][Full Text] [Related]
9. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
[TBL] [Abstract][Full Text] [Related]
10. Exonic deletions in AUTS2 cause a syndromic form of intellectual disability and suggest a critical role for the C terminus.
Beunders G; Voorhoeve E; Golzio C; Pardo LM; Rosenfeld JA; Talkowski ME; Simonic I; Lionel AC; Vergult S; Pyatt RE; van de Kamp J; Nieuwint A; Weiss MM; Rizzu P; Verwer LE; van Spaendonk RM; Shen Y; Wu BL; Yu T; Yu Y; Chiang C; Gusella JF; Lindgren AM; Morton CC; van Binsbergen E; Bulk S; van Rossem E; Vanakker O; Armstrong R; Park SM; Greenhalgh L; Maye U; Neill NJ; Abbott KM; Sell S; Ladda R; Farber DM; Bader PI; Cushing T; Drautz JM; Konczal L; Nash P; de Los Reyes E; Carter MT; Hopkins E; Marshall CR; Osborne LR; Gripp KW; Thrush DL; Hashimoto S; Gastier-Foster JM; Astbury C; Ylstra B; Meijers-Heijboer H; Posthuma D; Menten B; Mortier G; Scherer SW; Eichler EE; Girirajan S; Katsanis N; Groffen AJ; Sistermans EA
Am J Hum Genet; 2013 Feb; 92(2):210-20. PubMed ID: 23332918
[TBL] [Abstract][Full Text] [Related]
11. Attention Deficit Hyperactivity and Autism Spectrum Disorders as the Core Symptoms of AUTS2 Syndrome: Description of Five New Patients and Update of the Frequency of Manifestations and Genotype-Phenotype Correlation.
Sanchez-Jimeno C; Blanco-Kelly F; López-Grondona F; Losada-Del Pozo R; Moreno B; Rodrigo-Moreno M; Martinez-Cayuelas E; Riveiro-Alvarez R; Fenollar-Cortés M; Ayuso C; Rodríguez de Alba M; Lorda-Sanchez I; Almoguera B
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573342
[TBL] [Abstract][Full Text] [Related]
12. Identification of disrupted AUTS2 and EPHA6 genes by array painting in a patient carrying a de novo balanced translocation t(3;7) with intellectual disability and neurodevelopment disorder.
Schneider A; Puechberty J; Ng BL; Coubes C; Gatinois V; Tournaire M; Girard M; Dumont B; Bouret P; Magnetto J; Baghdadli A; Pellestor F; Geneviève D
Am J Med Genet A; 2015 Dec; 167A(12):3031-7. PubMed ID: 26333717
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel candidate disease genes from de novo exonic copy number variants.
Gambin T; Yuan B; Bi W; Liu P; Rosenfeld JA; Coban-Akdemir Z; Pursley AN; Nagamani SCS; Marom R; Golla S; Dengle L; Petrie HG; Matalon R; Emrick L; Proud MB; Treadwell-Deering D; Chao HT; Koillinen H; Brown C; Urraca N; Mostafavi R; Bernes S; Roeder ER; Nugent KM; Bader PI; Bellus G; Cummings M; Northrup H; Ashfaq M; Westman R; Wildin R; Beck AE; Immken L; Elton L; Varghese S; Buchanan E; Faivre L; Lefebvre M; Schaaf CP; Walkiewicz M; Yang Y; Kang SL; Lalani SR; Bacino CA; Beaudet AL; Breman AM; Smith JL; Cheung SW; Lupski JR; Patel A; Shaw CA; Stankiewicz P
Genome Med; 2017 Sep; 9(1):83. PubMed ID: 28934986
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of small copy number variants in neurodevelopmental disorders.
Asadollahi R; Oneda B; Joset P; Azzarello-Burri S; Bartholdi D; Steindl K; Vincent M; Cobilanschi J; Sticht H; Baldinger R; Reissmann R; Sudholt I; Thiel CT; Ekici AB; Reis A; Bijlsma EK; Andrieux J; Dieux A; FitzPatrick D; Ritter S; Baumer A; Latal B; Plecko B; Jenni OG; Rauch A
J Med Genet; 2014 Oct; 51(10):677-88. PubMed ID: 25106414
[TBL] [Abstract][Full Text] [Related]
15. Two male adults with pathogenic AUTS2 variants, including a two-base pair deletion, further delineate the AUTS2 syndrome.
Beunders G; de Munnik SA; Van der Aa N; Ceulemans B; Voorhoeve E; Groffen AJ; Nillesen WM; Meijers-Heijboer EJ; Frank Kooy R; Yntema HG; Sistermans EA
Eur J Hum Genet; 2015 Jun; 23(6):803-7. PubMed ID: 25205402
[TBL] [Abstract][Full Text] [Related]
16. Generation of an induced pluripotent stem cell line (SDQLCHi008-A) from a patient with ASD and DD carrying an 830 kb de novo deletion at chr7q11.22 including the exon 1 of AUTS2 gene.
Yang X; Zhou T; Zhang H; Li Y; Dong R; Liu N; Pan G; Liu Y; Gai Z
Stem Cell Res; 2019 Oct; 40():101557. PubMed ID: 31505389
[TBL] [Abstract][Full Text] [Related]
17. De novo intragenic deletion of the autism susceptibility candidate 2 (AUTS2) gene in a patient with developmental delay: a case report and literature review.
Jolley A; Corbett M; McGregor L; Waters W; Brown S; Nicholl J; Yu S
Am J Med Genet A; 2013 Jun; 161A(6):1508-12. PubMed ID: 23650183
[No Abstract] [Full Text] [Related]
18. AUTS2 Syndrome in a 68-year-old female: Natural history and further delineation of the phenotype.
Sengun E; Yararbas K; Kasakyan S; Alanay Y
Am J Med Genet A; 2016 Dec; 170(12):3231-3236. PubMed ID: 27531620
[TBL] [Abstract][Full Text] [Related]
19. Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders.
Mikhail FM; Lose EJ; Robin NH; Descartes MD; Rutledge KD; Rutledge SL; Korf BR; Carroll AJ
Am J Med Genet A; 2011 Oct; 155A(10):2386-96. PubMed ID: 22031302
[TBL] [Abstract][Full Text] [Related]
20. FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum.
Reuter MS; Riess A; Moog U; Briggs TA; Chandler KE; Rauch A; Stampfer M; Steindl K; Gläser D; Joset P; ; Krumbiegel M; Rabe H; Schulte-Mattler U; Bauer P; Beck-Wödl S; Kohlhase J; Reis A; Zweier C
J Med Genet; 2017 Jan; 54(1):64-72. PubMed ID: 27572252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
